Generac Holdings Inc. · GNRC · FY2024 Q3 · Calendar Q4 2024
Generac raises outlook as hurricane-driven residential demand surges
The quarter supports a constructive but conditional view: resilient residential demand, margin expansion, and new microgrid and storage initiatives strengthen the growth case, while hurricane dependence and weak C&I and European markets remain material offsets.
Earnings scorecard
Reported versus consensusMarket reaction
prior-close to event-session closeAsk FN2 about GNRC FY2024 Q3
Transcript, numbers and history already loadedFree account. Your question opens in FN2 with this report's transcript and numbers attached.
Transcript intelligence
What changed
The latest quarter shifted the near-term picture toward stronger residential demand and higher profitability: sales rose 10%, residential sales rose 28%, and management raised its full-year outlook. The mix remains uneven because C&I and European markets are still weak.
Guidance delta
Management raised FY2024 guidance to 5%-9% net-sales growth, gross margin up about 450 basis points, and adjusted EBITDA margin of 17.5%-18.5%.
Key takeaways
- Q3 sales increased 10%, with residential sales up 28% as hurricane-related outages lifted demand.
- Management cited record-high gross margins and raised its full-year 2024 outlook.
- C&I and European markets remained weak, while Latin America, microgrids, and energy storage offered growth avenues.
- PWRcell 2, the ecobee ecosystem, and microgrid initiatives are central to the product roadmap.
Management priorities
- Ramp home-standby production at the Whitewater and Trenton plants.
- Expand residential dealers and contractors in hurricane-impacted regions.
- Launch PWRcell 2 and deepen ecobee and Wallbox integration.
- Develop microgrid deployments supported by Department of Energy funding.
Follow GNRC with an agent that reads every filing, transcript, and price print. Free to start.
Try FN2 freeEarnings History
Analyst 52W Price Targets
Latest persisted target per named analyst; persisted current price from FN2's market snapshot as of Oct 19, 2026. Not an FN2 forecast.
Firm-level rating actions
FMP grade actions identify the grading firm, not a named analyst.
| Firm | Rating | Prior rating | Action | Date |
|---|---|---|---|---|
| Keybanc | Overweight | Sector Weight | Upgrade | Oct 8, 2026 |
| Cantor Fitzgerald | Overweight | Overweight | Maintain | Oct 5, 2026 |
| Stifel | Buy | Buy | Maintain | Sep 30, 2026 |
| Citigroup | Neutral | Neutral | Maintain | Sep 30, 2026 |
| JP Morgan | Overweight | Overweight | Maintain | Sep 18, 2026 |
| Stephens & Co. | Overweight | Overweight | Maintain | Sep 17, 2026 |
| Roth Capital | Neutral | Neutral | Maintain | Sep 17, 2026 |
| Needham | Buy | Buy | Maintain | Sep 17, 2026 |
| Canaccord Genuity | Buy | Buy | Maintain | Sep 17, 2026 |
| UBS | Buy | Buy | Maintain | Aug 4, 2026 |
| Barclays | Equal Weight | Equal Weight | Maintain | Jul 30, 2026 |
| Jefferies | Buy | Hold | Upgrade | May 22, 2026 |
| Wells Fargo | Overweight | Overweight | Maintain | May 1, 2026 |
| TD Cowen | Buy | Buy | Maintain | Apr 30, 2026 |
| Argus Research | Buy | Buy | Maintain | Apr 30, 2026 |
| B of A Securities | Buy | Buy | Maintain | Mar 26, 2026 |
| Guggenheim | Neutral | Buy | Downgrade | Feb 12, 2026 |
| Baird | Outperform | Neutral | Upgrade | Jan 9, 2026 |
| TD Securities | Buy | Buy | Maintain | May 1, 2025 |
| Piper Sandler | Overweight | Overweight | Maintain | Apr 17, 2025 |
| Goldman Sachs | Buy | Buy | Maintain | Feb 13, 2025 |
| Truist Securities | Buy | Buy | Maintain | Jan 16, 2025 |
| Roth MKM | Neutral | Neutral | Maintain | Oct 22, 2024 |
| Northland Capital Markets | Outperform | Outperform | Maintain | Aug 1, 2024 |
| Scotiabank | Sector Perform | Sector Perform | Maintain | Jul 29, 2024 |
| Janney Montgomery Scott | Neutral | Buy | Downgrade | Jun 13, 2024 |
| Oppenheimer | Outperform | Outperform | Maintain | May 2, 2024 |
| OTR Global | Positive | Mixed | Upgrade | Apr 2, 2024 |
| William Blair | Outperform | Outperform | Maintain | Jul 6, 2023 |
| Credit Suisse | Outperform | Outperform | Maintain | Feb 2, 2023 |
| Cowen & Co. | Outperform | Outperform | Maintain | Sep 30, 2022 |
| Colliers Securities | Buy | Buy | Maintain | Dec 15, 2021 |
| JMP Securities | Market Outperform | Market Outperform | Maintain | Feb 12, 2021 |
| Bank of America | Neutral | Buy | Downgrade | Nov 1, 2019 |
| Northcoast Research | Buy | Neutral | Upgrade | May 3, 2019 |
| Stifel Nicolaus | Hold | Hold | Maintain | Aug 2, 2018 |
| SunTrust Robinson Humphrey | Buy | Hold | Upgrade | Feb 14, 2018 |
| Wolfe Research | Perform | Peer Perform | Maintain | Jul 11, 2017 |
| BMO Capital | Outperform | Outperform | Maintain | Nov 12, 2012 |
Named analyst price targets
Upside is calculated against the persisted current price $194.98. FMP does not supply a rating on these named-analyst rows.
| Firm | Analyst | 52W target | Price when posted | Upside | Date |
|---|---|---|---|---|---|
| Piper Sandler | Dimple Gosai | $303 | $221.34 | +55.4% | Oct 8, 2026 |
| KeyBanc | Jeffrey Hammond | $280 | $221.34 | +43.6% | Oct 8, 2026 |
| Cantor Fitzgerald | Analyst unavailable | $297 | $216.8 | +52.3% | Oct 5, 2026 |
| Stifel Nicolaus | Stephen Gengaro | $290 | $212.22 | +48.7% | Sep 30, 2026 |
| Wells Fargo | Analyst unavailable | $280 | $207.23 | +43.6% | Sep 17, 2026 |
| Roth Capital | Analyst unavailable | $250 | $209.81 | +28.2% | Sep 17, 2026 |
| Raymond James | Tanner James | $286 | $175.11 | +46.7% | Sep 17, 2026 |
| Canaccord Genuity | Analyst unavailable | $375 | $175.11 | +92.3% | Sep 17, 2026 |
| HSBC | Analyst unavailable | $333 | $175.11 | +70.8% | Sep 17, 2026 |
| UBS | Analyst unavailable | $340 | $207.77 | +74.4% | Aug 4, 2026 |
| Roth Capital | Analyst unavailable | $214 | $192.3 | +9.8% | Jul 30, 2026 |
| D.A. Davidson | Analyst unavailable | $333 | $192.85 | +70.8% | Jul 30, 2026 |
| Cantor Fitzgerald | Analyst unavailable | $333 | $196.07 | +70.8% | Jul 30, 2026 |
| Robert W. Baird | Analyst unavailable | $305 | $191.26 | +56.4% | Jul 30, 2026 |
| Needham | Analyst unavailable | $283 | $195.19 | +45.1% | Jul 30, 2026 |
| Stifel Nicolaus | Stephen Gengaro | $285 | $195.19 | +46.2% | Jul 30, 2026 |
| Barclays | Analyst unavailable | $278 | $195.19 | +42.6% | Jul 30, 2026 |
| Cantor Fitzgerald | Analyst unavailable | $325 | $215.61 | +66.7% | Jul 22, 2026 |
| Barclays | Analyst unavailable | $285 | $278.62 | +46.2% | Jun 29, 2026 |
| UBS | Analyst unavailable | $335 | $239.11 | +71.8% | Jun 11, 2026 |
| Jefferies | Analyst unavailable | $302 | $247.79 | +54.9% | May 22, 2026 |
| Raymond James | Tanner James | $302 | $247.79 | +54.9% | May 22, 2026 |
| UBS | Analyst unavailable | $305 | $263 | +56.4% | May 5, 2026 |
| Stephens | Analyst unavailable | $290 | $257 | +48.7% | May 1, 2026 |
| Roth Capital | Chip Moore | $257 | $254.23 | +31.8% | Apr 30, 2026 |
| Argus Research | John Eade | $290 | $257.78 | +48.7% | Apr 30, 2026 |
| Stifel Nicolaus | Analyst unavailable | $275 | $256.29 | +41.0% | Apr 30, 2026 |
| Canaccord Genuity | Analyst unavailable | $325 | $252.92 | +66.7% | Apr 30, 2026 |
| Robert W. Baird | Analyst unavailable | $311 | $252.92 | +59.5% | Apr 30, 2026 |
| Barclays | Christine Cho | $228 | $194.4 | +16.9% | Mar 27, 2026 |
| UBS | Jon Windham | $270 | $215.04 | +38.5% | Feb 13, 2026 |
| Barclays | Analyst unavailable | $213 | $223.72 | +9.2% | Feb 12, 2026 |
| Stifel Nicolaus | Analyst unavailable | $235 | $221.67 | +20.5% | Feb 12, 2026 |
| Roth Capital | Analyst unavailable | $220 | $214.99 | +12.8% | Feb 12, 2026 |
| Robert W. Baird | Michael Halloran | $292 | $214.99 | +49.8% | Feb 12, 2026 |
| Canaccord Genuity | Analyst unavailable | $275 | $214.99 | +41.0% | Feb 12, 2026 |
| Barclays | Analyst unavailable | $186 | $160.85 | -4.6% | Jan 20, 2026 |
| Canaccord Genuity | Analyst unavailable | $236 | $156.6 | +21.0% | Jan 13, 2026 |
| Robert W. Baird | Analyst unavailable | $199 | $148.79 | +2.1% | Jan 9, 2026 |
| Wells Fargo | Analyst unavailable | $195 | $136.99 | +0.0% | Dec 19, 2025 |
| Barclays | Analyst unavailable | $197 | $165.78 | +1.0% | Oct 31, 2025 |
| UBS | Analyst unavailable | $215 | $174.3 | +10.3% | Oct 30, 2025 |
| Roth Capital | Chip Moore | $184 | $180.86 | -5.6% | Oct 30, 2025 |
| Needham | Analyst unavailable | $248 | $183.96 | +27.2% | Oct 22, 2025 |
| Guggenheim | Analyst unavailable | $202 | $168.3 | +3.6% | Oct 9, 2025 |
| Barclays | Analyst unavailable | $188 | $165.67 | -3.6% | Oct 6, 2025 |
| Canaccord Genuity | Analyst unavailable | $240 | $164.26 | +23.1% | Sep 25, 2025 |
| UBS | Jon Windham | $220 | $181 | +12.8% | Jul 31, 2025 |
| Barclays | Analyst unavailable | $200 | $181 | +2.6% | Jul 30, 2025 |
| Stifel Nicolaus | Stephen Gengaro | $175 | $165.55 | -10.2% | Oct 31, 2024 |
| Truist Financial | Jordan Levy | $210 | $165.55 | +7.7% | Oct 31, 2024 |
| Goldman Sachs | Jerry Revich | $148 | $165.55 | -24.1% | Oct 31, 2024 |
| Citigroup | Vikram Bagri | $172 | $166.65 | -11.8% | Oct 21, 2024 |
| Piper Sandler | Kashy Harrison | $175 | $146.24 | -10.2% | Sep 24, 2024 |
| Canaccord Genuity | George Gianarikas | $200 | $155.68 | +2.6% | Aug 1, 2024 |
| Truist Financial | Jordan Levy | $170 | $147.8 | -12.8% | May 23, 2024 |
| Oppenheimer | Christopher Glynn | $145 | $127.63 | -25.6% | May 2, 2024 |
| Roth Capital | Chip Moore | $135 | $134.12 | -30.8% | Apr 23, 2024 |
| Canaccord Genuity | George Giankarikas | $150 | $131.34 | -23.1% | Apr 5, 2024 |
| CFRA | Strong Buy | $145 | $125.8 | -25.6% | Feb 7, 2024 |
| Truist Financial | Jordan Levy | $160 | $113.95 | -17.9% | Aug 4, 2023 |
| Canaccord Genuity | George Giankarikas | $175 | $135.54 | -10.2% | Feb 16, 2023 |
| Janney Montgomery | Sean Milligan | $160 | $91.15 | -17.9% | Dec 28, 2022 |
| Roth Capital | Philip Shen | $75 | $110.3 | -61.5% | Oct 20, 2022 |
| Compass Point | Mark Strouse | $461 | $249.79 | +136.4% | Jul 21, 2022 |
| Wells Fargo | Praneeth Satish | $285 | $213.05 | +46.2% | Jun 29, 2022 |
| J.P. Morgan | Mark Strouse | $455 | $259.5 | +133.4% | May 5, 2022 |
| J.P. Morgan | Mark Strouse | $469 | $316.44 | +140.5% | Feb 16, 2022 |
| Bank of America Securities | Ross Gilardi | $350 | $265.19 | +79.5% | Jan 26, 2022 |
| Truist Financial | Tristan Richardson | $425 | $286.19 | +118.0% | Jan 24, 2022 |
| UBS | Jon Windham | $480 | $323.73 | +146.2% | Jan 10, 2022 |
| Piper Sandler | Kashy Harrison | $481 | $316.55 | +146.7% | Jan 7, 2022 |
| Roth Capital | Philip Shen | $555 | $453.4 | +184.7% | Nov 3, 2021 |
| Guggenheim | Joseph Osha | $460 | $409.19 | +135.9% | Jun 28, 2021 |
Track every rating change on GNRC the moment it posts. Free to start.
Start freeCompany context
Snapshot as of publicationGenerac Holdings Inc. specializes in the engineering, manufacturing, and global distribution of diverse power generation systems, energy storage solutions, and related electrical products. The company caters to residential users, light commercial enterprises, and industrial sectors worldwide. At its core, Generac produces vital components such as engines, alternators, batteries, advanced electronic controls, and robust steel enclosures. For homeowners, the company provides a range of automatic standby generators, from 7.5kW up to 150kW, including air-cooled models (7.5kW-26kW) and more powerful liquid-cooled units (22kW-150kW). Many of these residential systems are compatible with Mobile Link, a remote monitoring platform. Generac also offers portable generators, spanning outputs from 800W to 17.5kW, alongside an extensive catalog of outdoor power equipment like trimmers, mowers, log splitters, and pressure washers.…
Historical context
All GNRC earningsIndustrials peers this season
Latest reports in the same sector| Company | Quarter | EPS surprise | Market move | Headline |
|---|---|---|---|---|
| JBHT J.B. Hunt Transport Services, Inc. | FY2026 Q3 · Calendar Q4 2026 | +0.6% | -2.0% | J.B. Hunt: Strong demand, but margin repair remains central |
| FAST Fastenal Company | FY2026 Q3 · Calendar Q4 2026 | +3.3% | +1.1% | Fastenal Q3: Share Gains and Digital Adoption Lift Growth |
Latest beats and misses
Who reports nextBeat on EPS
Missed on EPS
Get the GNRC recap when the next report posts
One email per quarter with the scorecard, the market reaction and what changed on the call. No account needed.
Sources
- Earnings call transcript and parsed analysis · 2026-05-11T10:29:34.698584+00:00
- FN2 earnings calendar · 2024-11-10T18:38:36.707185+00:00
- Polygon adjusted daily market bars · 2026-10-19T16:20:44.460876+00:00
- Financial Modeling Prep analyst price-target consensus and quote snapshot · 2026-10-19T16:20:44.458023+00:00
Methodology
Reported and consensus figures come from FN2's earnings event records. Market reaction and volume are calculated from daily adjusted bars around the event; abnormal move subtracts the SPY move over the same window.
Analyst target low, average, and high values are derived at request time from each named analyst's latest persisted FMP target. The current-price marker comes from FN2's persisted market snapshot. They are sell-side estimates, not an FN2 valuation or recommendation.
Transcript intelligence is a structured synthesis of the current and prior earnings-call analyses. Missing values stay missing and are never estimated.
By FN2 Research · Updated · As of 2026-10-19. For educational purposes only; not investment advice.